Earlier this year, the Food and Drug Administration reported that the number of new drug shortages was on the decline. Clearly this is positive news and a reflection of the hard work by multiple parties across the healthcare supply chain…
Supply Chain
The U.S. Food and Drug Administration has approved the first DNA test that serves as a primary screening for the human papillomavirus in women ages 25 and older.
The intravenous fluid shortage continues to hinder hospitals nationwide.
Zimmer and Biomet, two leading orthopedic and spine device companies, have agreed to merge in a deal worth almost $13.4 billion.
Zimmer and Biomet announced that their respective boards of directors have approved a definitive agreement, under which Zimmer will acquire Biomet in a transaction valued at approximately $13.35 billion.
Advertisement
The U.S. Food and Drug Administration has approved Sylvant (siltuximab) to treat multicentric Castleman's disease.
The U.S. Food and Drug Administration is requiring warning labels be added to injectable corticosteroids to describe potential serious, adverse neurological events.
Lake Forest, Ill.-based Hospira has voluntarily recalled one lot of 0.25% Marcaine, 10 ml, Single-dose Vial, Preservative Free, due to discolored solution and visible particles embedded in the glass.
Lexington, Mass.-based Cubist Pharmaceuticals has issued a voluntary recall of one lot of CUBICIN, an intravenously administered antibiotic, due to glass particles found in a single vial from this lot.
Medline Industries, based in Mundelein, Illinois, is a supply chain company to watch. Recent updates from the company include the purchase of disinfectant technology from Medtrol and the acquisition of anterior cervical fusion business from Amendia.